(KWR) Quaker Chemical - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7473161070
Stock: Fluids, Inhibitors, Greases, Lubricants
Total Rating 47
Risk 88
Buy Signal -0.33
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.59% |
| Yield on Cost 5y | 0.73% |
| Yield CAGR 5y | 5.24% |
| Payout Consistency | 99.4% |
| Payout Ratio | 37.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 33.9% |
| Relative Tail Risk | -8.21% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.63 |
| Alpha | 7.67 |
| Character TTM | |
|---|---|
| Beta | 1.256 |
| Beta Downside | 1.227 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.31% |
| CAGR/Max DD | -0.07 |
Description: KWR Quaker Chemical January 13, 2026
Quaker Chemical Corporation (NYSE: KWR), operating as Quaker Houghton, manufactures and markets a broad portfolio of formulated specialty chemicals and fluid management services for heavy-industrial applications, ranging from metal-removal and cleaning fluids to offshore subsea energy control fluids and specialty greases. Its customer base spans steel, aluminum, automotive, aerospace, offshore, can, mining, and metal-working sectors, and the firm has been in operation since 1918 with headquarters in Conshohocken, Pennsylvania.
In FY 2023 the company generated roughly $1.2 billion in revenue, delivering an adjusted EBITDA margin near 13%, while recent acquisitions in specialty greases have expanded its high-margin product mix. The specialty chemicals sub-industry is projected to grow at a 4% CAGR through 2028, driven by increasing regulatory pressure for low-emission manufacturing processes and the ongoing automation of metal-forming operations, both of which underpin demand for Quaker Houghton’s performance-enhancing fluids.
For a deeper quantitative view, the ValueRay platform offers a granular breakdown of KWR’s valuation metrics and scenario analyses.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -9.00m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -3.08 > 1.0 |
| NWC/Revenue: 30.18% < 20% (prev 30.63%; Δ -0.45% < -1%) |
| CFO/TA 0.05 > 3% & CFO 153.0m > Net Income -9.00m |
| Net Debt (725.1m) to EBITDA (140.2m): 5.17 < 3 |
| Current Ratio: 2.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.4m) vs 12m ago -2.48% < -2% |
| Gross Margin: 35.94% > 18% (prev 0.38%; Δ 3557 % > 0.5%) |
| Asset Turnover: 67.15% > 50% (prev 68.09%; Δ -0.94% > 0%) |
| Interest Coverage Ratio: 1.15 > 6 (EBITDA TTM 140.2m / Interest Expense TTM 44.0m) |
Altman Z'' 2.46
| A: 0.20 (Total Current Assets 946.0m - Total Current Liabilities 383.4m) / Total Assets 2.82b |
| B: 0.21 (Retained Earnings 584.7m / Total Assets 2.82b) |
| C: 0.02 (EBIT TTM 50.5m / Avg Total Assets 2.78b) |
| D: 0.34 (Book Value of Equity 486.7m / Total Liabilities 1.45b) |
| Altman-Z'' Score: 2.46 = A |
Beneish M -3.04
| DSRI: 1.03 (Receivables 436.2m/422.7m, Revenue 1.86b/1.86b) |
| GMI: 1.05 (GM 35.94% / 37.63%) |
| AQI: 0.97 (AQ_t 0.55 / AQ_t-1 0.56) |
| SGI: 1.00 (Revenue 1.86b / 1.86b) |
| TATA: -0.06 (NI -9.00m - CFO 153.0m) / TA 2.82b) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of KWR shares?
As of February 07, 2026, the stock is trading at USD 170.07 with a total of 212,674 shares traded.
Over the past week, the price has changed by +10.62%, over one month by +16.94%, over three months by +29.30% and over the past year by +24.68%.
Over the past week, the price has changed by +10.62%, over one month by +16.94%, over three months by +29.30% and over the past year by +24.68%.
Is KWR a buy, sell or hold?
Quaker Chemical has received a consensus analysts rating of 4.60.
Therefore, it is recommended to buy KWR.
- StrongBuy: 3
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the KWR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 172.3 | 1.3% |
| Analysts Target Price | 172.3 | 1.3% |
| ValueRay Target Price | 189.7 | 11.5% |
KWR Fundamental Data Overview February 03, 2026
P/E Forward = 18.3824
P/S = 1.4669
P/B = 1.9549
P/EG = 2.67
Revenue TTM = 1.86b USD
EBIT TTM = 50.5m USD
EBITDA TTM = 140.2m USD
Long Term Debt = 838.5m USD (from longTermDebt, last quarter)
Short Term Debt = 35.9m USD (from shortTermDebt, last quarter)
Debt = 897.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 725.1m USD (from netDebt column, last quarter)
Enterprise Value = 3.46b USD (2.73b + Debt 897.1m - CCE 172.0m)
Interest Coverage Ratio = 1.15 (Ebit TTM 50.5m / Interest Expense TTM 44.0m)
EV/FCF = 27.13x (Enterprise Value 3.46b / FCF TTM 127.5m)
FCF Yield = 3.69% (FCF TTM 127.5m / Enterprise Value 3.46b)
FCF Margin = 6.84% (FCF TTM 127.5m / Revenue TTM 1.86b)
Net Margin = -0.48% (Net Income TTM -9.00m / Revenue TTM 1.86b)
Gross Margin = 35.94% ((Revenue TTM 1.86b - Cost of Revenue TTM 1.19b) / Revenue TTM)
Gross Margin QoQ = 36.62% (prev 35.52%)
Tobins Q-Ratio = 1.23 (Enterprise Value 3.46b / Total Assets 2.82b)
Interest Expense / Debt = 1.41% (Interest Expense 12.6m / Debt 897.1m)
Taxrate = 43.67% (9.27m / 21.2m)
NOPAT = 28.5m (EBIT 50.5m * (1 - 43.67%))
Current Ratio = 2.47 (Total Current Assets 946.0m / Total Current Liabilities 383.4m)
Debt / Equity = 0.66 (Debt 897.1m / totalStockholderEquity, last quarter 1.36b)
Debt / EBITDA = 5.17 (Net Debt 725.1m / EBITDA 140.2m)
Debt / FCF = 5.69 (Net Debt 725.1m / FCF TTM 127.5m)
Total Stockholder Equity = 1.36b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.32% (Net Income -9.00m / Total Assets 2.82b)
RoE = -0.66% (Net Income TTM -9.00m / Total Stockholder Equity 1.36b)
RoCE = 2.30% (EBIT 50.5m / Capital Employed (Equity 1.36b + L.T.Debt 838.5m))
RoIC = 1.31% (NOPAT 28.5m / Invested Capital 2.17b)
WACC = 8.14% (E(2.73b)/V(3.63b) * Re(10.55%) + D(897.1m)/V(3.63b) * Rd(1.41%) * (1-Tc(0.44)))
Discount Rate = 10.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.40%
[DCF Debug] Terminal Value 75.03% ; FCFF base≈159.7m ; Y1≈136.7m ; Y5≈106.0m
Fair Price DCF = 66.37 (EV 1.88b - Net Debt 725.1m = Equity 1.15b / Shares 17.3m; r=8.14% [WACC]; 5y FCF grow -17.53% → 2.90% )
EPS Correlation: -26.00 | EPS CAGR: -44.45% | SUE: -4.0 | # QB: 0
Revenue Correlation: -21.71 | Revenue CAGR: 2.69% | SUE: 1.19 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.81 | Chg30d=-0.030 | Revisions Net=-1 | Analysts=4
EPS next Year (2026-12-31): EPS=8.44 | Chg30d=-0.052 | Revisions Net=-1 | Growth EPS=+18.4% | Growth Revenue=+4.2%
P/S = 1.4669
P/B = 1.9549
P/EG = 2.67
Revenue TTM = 1.86b USD
EBIT TTM = 50.5m USD
EBITDA TTM = 140.2m USD
Long Term Debt = 838.5m USD (from longTermDebt, last quarter)
Short Term Debt = 35.9m USD (from shortTermDebt, last quarter)
Debt = 897.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 725.1m USD (from netDebt column, last quarter)
Enterprise Value = 3.46b USD (2.73b + Debt 897.1m - CCE 172.0m)
Interest Coverage Ratio = 1.15 (Ebit TTM 50.5m / Interest Expense TTM 44.0m)
EV/FCF = 27.13x (Enterprise Value 3.46b / FCF TTM 127.5m)
FCF Yield = 3.69% (FCF TTM 127.5m / Enterprise Value 3.46b)
FCF Margin = 6.84% (FCF TTM 127.5m / Revenue TTM 1.86b)
Net Margin = -0.48% (Net Income TTM -9.00m / Revenue TTM 1.86b)
Gross Margin = 35.94% ((Revenue TTM 1.86b - Cost of Revenue TTM 1.19b) / Revenue TTM)
Gross Margin QoQ = 36.62% (prev 35.52%)
Tobins Q-Ratio = 1.23 (Enterprise Value 3.46b / Total Assets 2.82b)
Interest Expense / Debt = 1.41% (Interest Expense 12.6m / Debt 897.1m)
Taxrate = 43.67% (9.27m / 21.2m)
NOPAT = 28.5m (EBIT 50.5m * (1 - 43.67%))
Current Ratio = 2.47 (Total Current Assets 946.0m / Total Current Liabilities 383.4m)
Debt / Equity = 0.66 (Debt 897.1m / totalStockholderEquity, last quarter 1.36b)
Debt / EBITDA = 5.17 (Net Debt 725.1m / EBITDA 140.2m)
Debt / FCF = 5.69 (Net Debt 725.1m / FCF TTM 127.5m)
Total Stockholder Equity = 1.36b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.32% (Net Income -9.00m / Total Assets 2.82b)
RoE = -0.66% (Net Income TTM -9.00m / Total Stockholder Equity 1.36b)
RoCE = 2.30% (EBIT 50.5m / Capital Employed (Equity 1.36b + L.T.Debt 838.5m))
RoIC = 1.31% (NOPAT 28.5m / Invested Capital 2.17b)
WACC = 8.14% (E(2.73b)/V(3.63b) * Re(10.55%) + D(897.1m)/V(3.63b) * Rd(1.41%) * (1-Tc(0.44)))
Discount Rate = 10.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.40%
[DCF Debug] Terminal Value 75.03% ; FCFF base≈159.7m ; Y1≈136.7m ; Y5≈106.0m
Fair Price DCF = 66.37 (EV 1.88b - Net Debt 725.1m = Equity 1.15b / Shares 17.3m; r=8.14% [WACC]; 5y FCF grow -17.53% → 2.90% )
EPS Correlation: -26.00 | EPS CAGR: -44.45% | SUE: -4.0 | # QB: 0
Revenue Correlation: -21.71 | Revenue CAGR: 2.69% | SUE: 1.19 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.81 | Chg30d=-0.030 | Revisions Net=-1 | Analysts=4
EPS next Year (2026-12-31): EPS=8.44 | Chg30d=-0.052 | Revisions Net=-1 | Growth EPS=+18.4% | Growth Revenue=+4.2%